About the Event
Tech4Eva invites you to attend this free online event on October 6th, where you will be able to meet some of the key industry experts from the Swiss and UK Femtech ecosystem. Join us to connect with investors, experts, and leaders in the healthcare space to hear about growth and partnership strategies, founders’ stories, and investment opportunities to scale your start-up. You will also find out about the collaboration opportunities in this space, practical insights into building a successful Femtech company and hear pitches from Tech4Eva’s growth start-ups.
Globally, the Femtech market is estimated to be worth $50 billion by 2025, according to research firm Frost & Sullivan. Regionally, the industry is projected to be worth $3.8 billion by 2031, with a growth rate of 15% from 2021 to 2031, according to a report by FemTech Analytics.
And although the Femtech industry is booming with innovation and topics around women's health are leaving the realm of taboo, there are still many areas that haven’t been researched enough, haven’t received enough funding, or, simply, are still seen to be ‘niche’, such as endometriosis, PCOS, female mental health and neurodiversity, postpartum care, female cardiovascular health and many more.
During our first panel session “Answering the unmet needs in women’s health”, we will be discussing the unmet needs in women's health that are yet to be answered and addressed through innovation and investment in the space, as well as the role of technology in addressing those needs.
The second panel discussion “Running a successful Femtech company” will focus on the three successful industry speakers on how they see the landscape evolving, what can we expect from the Femtech space in the near future, and how did their own journey in this industry look like.
-Learn about unmet needs in women's health
-Get insights about the ecosystem in the UK and what it takes to build a successful start-up
-Meet the innovative solutions of the Tech4Eva start-ups
Charlotte Chenu is the Science and Innovation officer at the Embassy of Switzerland in the UK, where she manages the Innosuisse Internationalisation Programme. She graduated from the business school of the University of Lausanne (HEC), and now supports innovative Swiss startups entering the UK market. Along her career in Switzerland, India and now in the UK, Charlotte has built several programmes and events that support entrepreneurs at every stage of their growth. She has successfully guided Swiss startups in their journey by advising them on their internationalisation strategy and connecting them to investors, corporates and partners.
Lan is the Deputy Managing Director of EPFL Innovation Park and an Expert of Innosuisse – the Swiss Innovation Agency. She has 23 years of hands-on professional experience in industry as well as in the ecosystem of innovation & entrepreneurship.
Lan started her career at R&D department of Rolex, in charge of creating new computer aided design and optimisation tools in the product development process. She was later appointed as Head of Operational Planning at Pictet, working closely with a startup to design, develop and implement a management information system for group operation control. As the Managing Director of Geneva Creativity Center, she connected large corporations, SMEs, startups and researchers to initiate innovative joint R&D projects.
Currently at EPFL Innovation Park, she is leading entrepreneurship training and acceleration programs and is helping startups to establish business partnership with large corporations. Lan has a PhD degree from EPFL, an MBA from HEC Lausanne and postdoctoral applied research experience at Stanford University.
Mathieu is co-founder and CEO of ASPIVIX SA. He has over ten years of experience in the development and commercial management of medical devices.
He brings a strong track record of building and leading diverse and cross-functional teams for both start-ups and Fortune 500 companies in the life sciences and medical device sector at ASPIVIX and Danaher.
With ASPIVIX, he is a pioneer in FemTech - innovative gynecological devices - and has raised more than US$10 million in dilutive and non-dilutive financing rounds.
Mathieu holds several master's degrees in mechanics from Paris Tech in France, Cranfield University in the UK, and IFP School in France, as well as an MBA from INSEAD/Wharton, France-Singapore-Philadelphia.
Currently heading Strategic Excellence, for Merck Healthcare with overall accountability for Strategy Development and Strategic Planning, Global Strategic Insights (Forecasting, Market Research and Business Intelligence), Portfolio Management and Valuation and Strategic Alliances. My focus is on architecting the Healthcare strategy for Merck, project and portfolio decision making and overseeing business-critical strategic alliances. Additionally, I undertake a number of governance roles including chairing both the Supervisory board for the Merck-Pfizer alliance and the MVentures Healthcare Investment Committee. I am also a member of the Boards of Ares Trading S.A., Merck B.V. and Merck Performance Materials S.A..
I most recently led Biopharma Marketing and Strategy Operations and prior to that served as the Head of Global Business Development and Alliance Management within the Biopharma business of Merck. Here I was responsible for all partnering activities, taking the global lead role for identifying and executing Global Business Development opportunities for Merck Biopharma's R&D, and also the commercial portfolio plus Alliance Management closing the alliance with Pfizer on PDL1, the single biggest licensing transaction for a clinical stage asset for any company globally.
Daniela Schardinger is an experienced Vice President (VP) Marketing & Medical Affairs at OCON Healthcare, a women’s health company introducing innovative medical solutions that allow women healthier choices while improving their well-being and quality of life.
Ms. Schardinger has vast experience in Marketing & Sales, Medical Affairs and Management in the medical and pharmaceutical industries specializing in women’s health around the globe for the past decade. She was recently featured on the Forbes SUPERWOMAN series (DACH) for her work in FemTech.
Prior to joining OCON Healthcare, Ms. Schardinger led and built up a Swiss Pharmaceutical Company (Gynial AG) as Managing Director - a Women’s Health Firm focusing on bringing innovative medical solutions for women to the market.
Priya conceptualised and started to build Goddess Gaia Ventures (GGV) in 2021 after a long held belief that women’s healthcare is greatly underserved and underfunded and there remains huge, untapped market potential in this investment vertical. GGV is Europe’s first women’s centred healthcare fund investing in solutions across the spectrum of women’s health. Priya is an avid angel investor and has demonstrated access and a winning formula when investing into promising start ups in GGV ‘s investment vertical.
Priya is also the founder of Oberoi Capital Partners, a regulated company she built from the ground up. She built, managed and ran the firm for over ten years, providing fund raising expertise, strategic business advice and multi-channel scale-up positioning across different asset classes and distinct investment strategies.
Priya is a finance and derivatives lawyer by background and training, attaining of-counsel recognition in 2010 at a magic circle law firm.
Priya holds a BA (Hons) and MA in Jurisprudence from Oxford University.
FemTech innovator and entrepreneur Kim Palmer is the CEO and Founder of the hypnotherapy app Clementine, which aims to improve the emotional wellbeing of women all over the world. Born after Kim experienced a number of panic attacks whilst pregnant, Clementine has been created to make women feel calmer, more confident and better equipped to cope with everyday life.
The hypnotherapy sessions available on the Clementine app can be used to boost confidence or help you return to sleep by guiding you to relaxed state, similar to daydreaming, and suggests new ways to deal with everyday grievances; allowing you to kick back and continue your daily routine.
Kim was recently named in the longlist of incredible women in Health Tech (2022). Listed as one of the top 100 women in Fem Tech & Health Tech and winner of the IPA Campaign Women of Tomorrow in 2018, which recognises female industry leaders of the future.
Whilst working at Wunderman Thompson as a strategy director, Kim also helped some of the world’s biggest brands with their global marketing campaigns and was able to develop her personal resilience and kick-start a women’s mentoring programme.
Time zone CET
16:00 Welcome Remarks & Intros
Speakers: Lan Zuo Gillet, Deputy Managing Director of EPFL Innovation Park, Charlotte Chenu, Innovation Project Manager of the Embassy of Switzerland in the UK
16:10 Panel Discussion with Q&A: "Answering the unmet needs"
Speakers: Priya Oberoi, General Partner of Goddess Gaia Ventures
16:40 Tech4Eva Showcase of Selected Growth Stage Start-ups
7 Start-ups: Sabrina Badir of Pregnolia, Sven Mulfinger of Dana Health, Oana Gharbi of Proov, Liza Velarde of Delee, Rob Milnes of Vio Healthtech, Rebecca Sternberg of AquaFit, and Cristina Rossi of b-rayZ
16:50 Panel Discussion with Q&A: "Building a successful Femtech company"
Speakers: Matthieu Horras, CEO & Co-Founder of Aspivix (Tech4Eva Alumni), Kim Palmer, Founder of Clementine and Daniela Schardinger, VP Marketing & Medical Affairs of OCON Healthcare
Moderator: Susan Herbert, Global Head of Strategic Excellence at Healthcare Business of Merck group
17:20 Tech4Eva Showcase of Selected Growth Stage Start-ups
7 Start-ups: David Stoikovitch of Moona, Tzali Cnaani of Carmel Diagnostics, Eva Galant of Hashiona, Marc Finch of PreTel, Nadia Prisant of IMMA, Ruben Molina of INNITIUS, and Hélène Guillaume Pabis of Wild AI